Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 79

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Histamine-1 receptor antagonism for treatment of insomnia

Vande Griend, Joseph P., Anderson, Sarah L. · 2012 · Journal of the American Pharmacists Association

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1331/japha.2012.12051

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 37

  1. Summers, 2006, Recent developments in the classification, evaluation, and treatment of insomnia, Chest, 130, 276, 10.1378/chest.130.1.276 · DOI
  2. Bhat, 2008, Pharmacotherapy of insomnia, Expert Opin Pharmacother, 9, 351, 10.1517/14656566.9.3.351 · DOI
  3. Ozminkowski, 2007, The direct and indirect costs of untreated insomnia in adults in the United States, Sleep, 30, 263, 10.1093/sleep/30.3.263 · DOI · Paper page
  4. Walsh, 1999, The direct economic costs of insomnia in the United States for 1995, Sleep, 22, S386
  5. Ramesh, 2004, Wakefulness-inducing effects of histamine in the basal forebrain of freely moving rats, Behav Brain Res, 152, 271, 10.1016/j.bbr.2003.10.031 · DOI
  6. Strecker, 2002, Extracellular histamine levels in the feline preoptic/anterior hypothalamic area during natural sleep-wakefulness and prolonged wakefulness: an in vivo microdialysis study, Neuroscience, 113, 663, 10.1016/S0306-4522(02)00158-6 · DOI
  7. Stahl, 2008, Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines, CNS Spectr, 13, 1027, 10.1017/S1092852900017089 · DOI · Paper page
  8. Glass, 2008, Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trial, J Clin Psychopharmacol, 28, 182, 10.1097/JCP.0b013e31816a9e4f · DOI
  9. Rickels, 1983, Diphenhydramine in insomniac family practice patients: a double-blind study, J Clin Pharmacol, 23, 234, 10.1002/j.1552-4604.1983.tb02730.x · DOI
  10. Meuleman, 1987, Evaluation of temazepam and diphenhydramine as hypnotics in a nursing-home population, Drug Intell Clin Pharm, 21, 716, 10.1177/106002808702100908 · DOI
  11. Sjoqvist, 1967, The hypnotic efficacy of doxylamine, Clin Pharmacol Ther, 8, 48, 10.1002/cpt196781part148 · doi:10.1002/cpt196781part148
  12. Winokur, 2000, Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study, Biol Psychiatry, 48, 75, 10.1016/S0006-3223(00)00882-9 · DOI · Paper page
  13. Cankurtaran, 2008, Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine, Support Care Cancer, 16, 1291, 10.1007/s00520-008-0425-1 · DOI
  14. Kim, 2008, Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression, Psychiatry Clin Neurosci, 62, 75, 10.1111/j.1440-1819.2007.01778.x · DOI
  15. Radhakishun, 2000, Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens, J Clin Psychopharmacol, 20, 531, 10.1097/00004714-200010000-00006 · DOI
  16. Ruigt, 1990, Effect of the antidepressant Org 3770 on human sleep, Eur J Clin Pharmacol, 38, 551, 10.1007/BF00278580 · DOI · Paper page
  17. Shen, 2006, Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine, Can J Psychiatry, 51, 27, 10.1177/070674370605100106 · DOI
  18. Schittecatte, 2002, Effects of mirtazapine on sleep polygraphic variables in major depression, Neuropsychobiology, 46, 197, 10.1159/000067812 · DOI
  19. Bon O, 2003, Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations, J Clin Psychopharmacol, 23, 377, 10.1097/01.jcp.0000085411.08426.d3 · DOI · Paper page
  20. Walsh, 1998, Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia, Human Psychopharmacol, 13, 191, 10.1002/(SICI)1099-1077(199804)13:3<191::AID-HUP972>3.0.CO;2-X · doi:10.1002/(sici)1099-1077(199804)13:3<191::aid-hup972>3.0.co;2-x
  21. Roth, 2011, Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs, J Sleep Res, 20, 552, 10.1111/j.1365-2869.2011.00928.x · DOI
  22. Stein, 2011, Trazodone for sleep disturbance during methadone maintenance: a double-blind, placebo-controlled trial, Drug Alcohol Depend, 120, 65, 10.1016/j.drugalcdep.2011.06.026 · DOI
  23. Roth, 2007, Efficacy and safety of doxepin 1mg, 3mg, and 6mg in adults with primary insomnia, Sleep, 30, 1555, 10.1093/sleep/30.11.1555 · DOI · Paper page
  24. Scharf, 2008, Efficacy and safety of doxepin 1mg, 3mg, and 6mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study, J Clin Psychiatry, 69, 1557, 10.4088/JCP.v69n1005 · DOI
  25. Krystal, 2010, Efficacy and safety of doxepin 1mg and 3mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia, Sleep, 33, 1553, 10.1093/sleep/33.11.1553 · DOI · Paper page
  26. Roth, 2010, Efficacy and safety of doxepin 6mg in a model of transient insomnia, Sleep Med, 11, 843, 10.1016/j.sleep.2010.07.006 · DOI
  27. Krystal, 2011, Efficacy and safety of doxepin 3 and 6mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia, Sleep, 34, 1433
  28. Lankford, 2011, Efficacy and safety of doxepin 6mg in a four-week outpatient trial of elderly adults with chronic primary insomnia, Sleep Med, 13, 133, 10.1016/j.sleep.2011.09.006 · DOI
  29. Schweitzer, 1994, Sleepiness and performance during three-day administration of cetirizine or diphenhydramine, J Allergy Clin Immunol, 94, 716, 10.1016/0091-6749(94)90179-1 · DOI
  30. Manning, 1992, Central nervous system effects of meclizine and dimenhydrinate: evidence of acute tolerance to antihistamines, J Clin Pharmacol, 32, 996, 10.1002/j.1552-4604.1992.tb03801.x · DOI
  31. Bye, 1977, Evidence for tolerance to the central nervous effects of the histamine antagonist, triprolidine, in man, Eur J Clin Pharmacol, 12, 181, 10.1007/BF00609857 · DOI
  32. Levander, 1991, Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine, Eur J Clin Pharmacol, 41, 435, 10.1007/BF00626365 · DOI
  33. Monti, 2000, Histamine H1 receptor antagonists in the treatment of insomnia: is there a rational basis for use?, CNS Drugs, 13, 87, 10.2165/00023210-200013020-00002 · DOI
  34. Stimmel, 1997, Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects, Pharmacotherapy, 17, 10, 10.1002/j.1875-9114.1997.tb03674.x · DOI · Paper page
  35. Thase, 1999, Antidepressant treatment of the depressed patient with insomnia, J Clin Psychiatry, 60, 28
  36. Fox, 2009, Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly, Pharmacotherapy, 29, 383, 10.1592/phco.29.4.383 · DOI
  37. Roy, 2010, Prevalence and cost of insomnia in a state Medicaid fee-for-service population based on diagnostic codes and prescription utilization, Sleep Med, 11, 462, 10.1016/j.sleep.2009.09.012 · DOI

Cited by

See all 79

Metadata

Authors
Vande Griend, J. P., & Anderson, S. L.
Venue
Journal of the American Pharmacists Association
Publisher
Elsevier BV
Published
2012-11
Volume
52
Issue
6
Pages
e210-e219
ISSN
1544-3191
Cited by
79
References
13
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.